
<![CDATA[DeLLphi-303 Study: Tarlatamab's Impact on Small Cell Lung Cancer]]>
In an interview with Targeted Oncology, Kelly Paulson, MD, Swedish Cancer Institute Medical Oncology, discusses the key takeaways for oncologists from the phase 1b DeLLphi-303 study presented at the IASLC 2025 World Conference on Lung Cancer. Paulson …